IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY) Stock Price Today | Quotes & News - Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

US Stock MarketDetailed Quotes

IPSEY IPSEN SA SPONS ADR EA REPR 0.25 ORD

Watchlist

30.060
+0.530+1.79%

15min DelayClose Mar 14 16:00 ET

9.94BMarket Cap26.70P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Ipsen S.A. (IPSEY) Q4 2024 Earnings Call Transcript Summary
moomoo AIFeb 13 11:27 ET · Conference Call
Ipsen Targets 5%+ Sales Growth and 30%+ Margin for 2025 Amid Strong Pipeline and Launches
Seeking AlphaFeb 13 11:25 ET
Here's the Major Earnings Before the Open Tomorrow
Seeking AlphaFeb 12 18:00 ET
Eton Pharmaceuticals Enters Asset Purchase Agreement To Acquire Increlex (Mecasermin Injection) From Ipsen; No Terms Disclosed
BenzingaOct 3, 2024 06:34 ET
Gilead Wins FDA Nod for Liver Disease Drug
Seeking AlphaAug 14, 2024 14:25 ET
Gilead Exits J&J Royalty Deal for Liver Drug Ahead of Potential FDA Nod
Seeking AlphaAug 10, 2024 08:13 ET

Comments

Jun 11, 2024 16:48

🔔 FDA PDUFA Update…

🚨 1 AdCom & 3 PDUFA decisions this week:
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : 🤔
⇨ Elafibranor
‣ Primary biliary cholangitis
‣ PDUFA date: 6/10/24
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Kevzara (sarilumab)
‣ Polyarticular juvenile idiopathic arthritis
‣ PDUFA date: 6/10/24
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Augtyro™ (Repotrectinib)
‣ PDUFA date: 6/15/24 (sNDA)
🗓️ Last week’s PDUFAs:
$GlaxoSmithKline (GSK.US)$ : Approved 6/7 🎉
⇨ Arexvy
‣ Respiratory s...

🔔 FDA PDUFA Update…

10

1

Jun 7, 2024 16:39

🚨 June PDUFAs

» 15+ upcoming FDA decisions to watch: 👀 👇
$GlaxoSmithKline (GSK.US)$ : Arexvy
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : Elafibranor
$Eli Lilly and Co (LLY.US)$ : Donanemab - AdCom meeting 🗓️
$Regeneron Pharmaceuticals (REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb (BMY.US)$ : Augtyro™ (Repotrectinib)
$Geron (GERN.US)$ : Imetelstat
$Merck & Co (MRK.US)$ : V116
$Amgen (AMGN.US)$ : BLINCYTO (blinatumomab)
$Sarepta Therapeutics (SRPT.US)$ : ELEVIDYS
$Merck & Co (MRK.US)$ : KEYTRUDA ...

🚨 June PDUFAs

16

4

May 24, 2024 16:20

See remaining FDA PDUFAs in May 👀👇
$Bristol-Myers Squibb (BMY.US)$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna (MRNA.US)$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals (CPRX.US)$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline (GSK.US)$ : Arexvy
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : Elafibranor
$Regeneron Pharmaceuticals (REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb (BMY.US)$ : Augtyro...

9

1

1

Read more